Web Analytics

3 Latest Announced Rounds

  • $100,000,000
    Series C

    6 Investors

    Biotechnology Research
    Jan 21st, 2025
  • $55,157,175
    Unknown

    2 Investors

    Investment Management
    Jan 21st, 2025
  • $1,000,000
    Seed
    Software Development
    Jan 21st, 2025
$1,083.28M Raised in 34 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Vaxess Technologies

start up
United States - Boston, MA
  • 14/09/2023
  • Unknown
  • $9,000,000

Vaxess Technologies is a venture capital and Gates Foundation-backed life science company developing novel vaccine formulations and delivery technologies based on its proprietary silk platform. We are committed to improving access to vaccines by enabling better, more stable vaccine products that can be easily delivered all over the world.
Find more information at www.vaxess.com.


Related People

Michael SchraderCo Founder

Michael Schrader United States - Boston, Massachusetts

N/A